TAC-STIM™ Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments Project
June 27, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., June 27, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its TAC-STIM non-invasive...
New Active Relaxation Product Empowers Pain Sufferers to Overcome Stress, Anxiety, and Sleepless Nights
June 15, 2023 10:00 ET
|
Avaria Health & Beauty Corp
TORONTO, June 15, 2023 (GLOBE NEWSWIRE) -- Canadians experiencing pain can now find solace in KaLaya's new, Vegan Blueberry Active Relaxation Gummies. These gummies are designed to alleviate stress,...
electroCore to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC
June 14, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., June 14, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
electroCore Announces Poster to be Presented at the American Headache Society’s 65th Annual Scientific Meeting
June 13, 2023 08:00 ET
|
electroCore, Inc.
ROCKAWAY, N.J., June 13, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that “SUNCT/ SUNA with...
Neurostimulation Devices Market Revenue is Predicted to Surpass a Valuation of US$ 36.5 billion by 2032, States by Market.us
May 24, 2023 06:57 ET
|
Market.Us
New York, May 24, 2023 (GLOBE NEWSWIRE) -- The Neurostimulation Devices Market stood at US$ 11.1 billion in 2022 and the global market is projected to reach US$ 36.5 billion by 2032. The global...
Botulinum Toxin Market to Reach Valuation of USD 13.4 Bn at CAGR of 8.4% by 2032
May 08, 2023 06:42 ET
|
Market.Us
New York, May 08, 2023 (GLOBE NEWSWIRE) -- In terms of revenue, The global Botulinum Toxin Market is estimated to exceed US$ 13.4 billion by 2032 from USD 6.1 billion in 2022, expanding at a CAGR of...
New SPRINT extensa XT™ System with Bimodal PNS™ Offers Synergistic Treatment of Pain
April 25, 2023 10:00 ET
|
SPR Therapeutics, Inc.
CLEVELAND, Ohio, April 25, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or...
Global Chronic Pain Market Size To worth $140.5 billion By 2030, CAGR of 5.8% | Spherical Insights
April 21, 2023 08:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , April 21, 2023 (GLOBE NEWSWIRE) -- The Global Chronic Pain Market Size to grow from USD 69.1 billion in 2021 to USD 140.5 billion by 2030, at a Compound Annual Growth Rate...
Intrathecal Pumps Market to Raise at a CAGR of 4.5% During 2022 to 2031 | TMR
March 28, 2023 11:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, March 28, 2023 (GLOBE NEWSWIRE) -- According to the latest study by Transparency Market Research, the global intrathecal pumps market stood at USD 280.5 Mn in...
SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference
March 16, 2023 08:00 ET
|
SPR Therapeutics, Inc.
CLEVELAND, March 16, 2023 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients suffering from acute or...